Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenAlex
Works that cite this article, indexed by OpenAlex.
Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals
Hepatitis Monthly 16(4) (2016)
Khashayar Hesamizadeh; Heidar Sharafi; Mohammad Saeid Rezaee Zavareh; Bita Behnava; Seyed Moayed Alavian
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline
Hepatitis Monthly 16(8) (2016)
Seyed Moayed Alavian; Behzad Hajarizadeh; Kamran Bagheri Lankarani; Heidar Sharafi; Nasser Ebrahimi Daryani; Shahin Merat; Minoo Mohraz; Masoud Mardani; Mohammad Reza Fattahi; Hossein Poustchi; Mehri Nikbin; Mahmood Nabavi; Peyman Adibi; Masood Ziaee; Bita Behnava; Mohammad Saeid Rezaee Zavareh; Massimo Giuseppe Colombo; Hatef Massoumi; Abdul Rahman Bizri; Bijan Eghtesad; Majid Valiollahpour Amiri; Ali Namvar; Khashayar Hesamizadeh; Reza Malekzadeh
The Role of Polymorphisms Near the IL28B Gene on Response to Peg-Interferon and Ribavirin in Thalassemic Patients With Hepatitis C
Hepatitis Monthly 16(1) (2016)
Bita Behnava; Heidar Sharafi; Maryam Keshvari; Ali Pouryasin; Leila Mehrnoush; Shima Salimi; Pegah Karimi Elizee; Mehran Ghazimoghadam; Seyed Moayed Alavian
The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C
Journal of Research in Medical Sciences 21(1) (2016)
Maryam Keshvari; Seyed Moayed Alavian; Bita Behnava; Ali Pouryasin; Heidar Sharafi
Impact ofIFNL4rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C
Journal of Clinical Laboratory Analysis 31(4) (2016)
Maryam Keshvari; Seyed Moayed Alavian; Bita Behnava; Ali Pouryasin; Johanna C. Craig; Heidar Sharafi
Treatment of chronic hepatitis C with pegylated interferon plus ribavirin in treatment-naïve ‘real-life’ patients in India
Indian Journal of Gastroenterology 33(4) (2014)
Ajit Sood; Vandana Midha; Omesh Goyal; Syed S Hissar; Suresh K. Sharma; Pankaj Khanna
Can we include genetic variants with high linkage disequilibrium into a multiple logistic model?
Liver International 34(6) (2014)
Maryam Keshvari; Heidar Sharafi; Behzad Hajarizadeh; Seyed Moayed Alavian
Efficacy of 24-Week Pegylated Interferon Alpha and Ribavirin Combination Therapy in Highly Selected Patients Infected With Hepatitis C Virus Genotype 1
Hepatitis Monthly 15(1) (2015)
Heidar Sharafi; Seyed Moayed Alavian; Maryam Keshvari
Predicting the Outcomes of Combination Therapy in Patients With Chronic Hepatitis C Using Artificial Neural Network
Hepatitis Monthly 14(5) (2014)
Forough Sargolzaee Aval; Nazanin Behnaz; Mohamad Reza Raoufy; Seyed Moayed Alavian
Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population
Clinics and Research in Hepatology and Gastroenterology 43(5) (2019)
Amitis Ramezani; Kazem Baesi; Mohammad Banifazl; Minoo Mohraz; Farzin Khorvash; Majid Yaran; Payam Tabarsi; Amir hosein Dalirrooyfard; Fatemeh Motevalli; Anahita Bavand; Arezoo Aghakhani
Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study.
PubMed 11(1) (2020)
Heidar Sharafi; Seyed Hoda Alavian; Bita Behnava; Mohammad Saeid Rezaee Zavareh; Mehri Nikbin; Seyed Moayed Alavian
The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis C
Hepatitis Monthly 16(2) (2016)
Mohammad Pouryasin; Maryam Keshvari; Heidar Sharafi; Seyed Moayed Alavian; Bita Behnava; Seyed Ehsan Alavian; Ali Pouryasin
Prevalence of hepatitis C virus NS5A resistance-associated substitutions in chronic infection with genotype 1: A pooled analysis based on deposited sequences in GenBank
Virus Research 259 (2018)
Heidar Sharafi; Saeideh Maleki; Seyed Moayed Alavian
The Role of Polymorphisms Near IFNL3 Gene as Predictors of Residual HCV RNA in Buffy Coat after Successful Antiviral Therapy
Hepatitis Monthly 17(4) (2017)
Seyyed Mohammad Miri; Heidar Sharafi; Ali Pouryasin; Bita Behnava; Maryam Keshvari; Shima Salimi; Pegah Karimi Elizee; Seyed Moayed Alavian
Assessment of Hepatitis C Virus RNA in Peripheral Blood Mononuclear Cells as a Predictor of Response to Pegylated-Interferon and Ribavirin: A Cohort Study
Iranian Red Crescent Medical Journal 19(5) (2017)
Seyyed Mohammad Miri; Heidar Sharafi; Shima Salimi; Farah Bokharaei‐Salim; Bita Behnava; Maryam Keshvari; Pegah Karimi Elizee; Hossein Keyvani; Seyed Moayed Alavian
Comment on “No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance” by Ubaldo Visco-Comandini et al. [Dig. Liver Dis. 2014;46:348–52]
Digestive and Liver Disease 46(8) (2014)
Maryam Keshvari; Heidar Sharafi; Seyed Moayed Alavian
Can IFNL3 polymorphisms predict response to interferon/ribavirin treatment in hepatitis C patients with genotype 3?
Journal of General Virology 97(10) (2016)
Sajid Mansoor; Sana Riaz; Sara Kausar; Sadia Muhammad Din; Aneela Javed; Aneesa Sultan; Atika Mansoor
Treatment results and factors affecting sustained virological response in chronic hepatitis C patients in Northern India
JOURNAL OF GASTROINTESTINAL INFECTIONS 5(1) (2015)
Deepinder Kaur; Rajoo Singh Chhina; Omesh Goyal; Prerna Goyal